ClinConnect ClinConnect Logo
Search / Trial NCT04695028

CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies

Launched by LILLE CATHOLIC UNIVERSITY · Jan 4, 2021

Trial Information

Current as of August 25, 2025

Recruiting

Keywords

Gout Chondrocalcinosis Hydroxyapatite

ClinConnect Summary

The CRYSTALILLE Cohort trial is focused on understanding and improving the treatment of certain types of arthritis caused by crystal deposits in the joints, specifically gout and other related conditions. Researchers aim to gather information from patients at the Groupement des Hôpitaux de l'Institut Catholique de Lille to create a detailed picture of these diseases. This study will use medical imaging techniques to help doctors better diagnose and manage these conditions.

To participate in this trial, you should be between 65 and 74 years old and have been diagnosed with gout, calcium pyrophosphate crystal disease, or hydroxyapatite crystal rheumatism. You should also be someone who has had or will benefit from an ultrasound or special type of scan to check for crystal deposits. If you join, you can expect to undergo imaging tests and provide some health information that will help researchers learn more about these conditions. It's important to know that if you have any reservations about participating or if you're unable to undergo the necessary imaging, you may not be eligible for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of gout according to American College of Rheumatology /European League Against Rheumatism (ACR/EULAR) 2015 criteria OR diagnosis of calcium pyrophosphate dihydrate crystal deposition disease (CPPD) based on EULAR 2011 recommendations OR diagnosis of hydroxyapatite crystal rheumatism (HCR) according to a typical clinical sequence and demonstration of compatible calcium deposits on imaging
  • patient who will benefit or has benefited from an ultrasound and/or DECT evaluation of microcrystalline deposits
  • clinical suspicion of microcrystalline rheumatism requiring further imaging to confirm the diagnosis
  • Exclusion Criteria:
  • Refusal or contra-indication to perform ultrasound or dual energy scanning.
  • Patient's opposition to the use of his or her health data for research purposes
  • Patient under guardianship or curatorship
  • Pregnant woman
  • Person not affiliated to a social security scheme or entitled to a social security benefit

About Lille Catholic University

Lille Catholic University, a prominent academic institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates expertise from various fields to foster the development of cutting-edge medical solutions. Its commitment to ethical standards and patient-centered approaches ensures that clinical trials conducted under its auspices are rigorous, scientifically sound, and aligned with the highest standards of care. By leveraging its extensive network of researchers, healthcare professionals, and resources, Lille Catholic University plays a vital role in contributing to the enhancement of medical knowledge and the improvement of patient outcomes.

Locations

Lomme, , France

Patients applied

0 patients applied

Trial Officials

Tristan Pascart, MD

Principal Investigator

GHICL

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials